07/23/2026 | Press release | Distributed by Public on 07/23/2026 06:01
TABLE OF CONTENTS
|
☐
|
Preliminary Proxy Statement
|
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☒
|
Definitive Proxy Statement
|
|
☐
|
Definitive Additional Materials
|
|
☐
|
Soliciting Material under §240.14a-12
|
|
|
|
TRANSCAT, INC.
|
|
(Name of Registrant as Specified In Its Charter)
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
|
|
☒
|
No fee required
|
|
☐
|
Fee paid previously with preliminary materials
|
|
☐
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
When:
Wednesday, September 9, 2026
12:00 p.m. Eastern Time
|
|
|
Where:
Via webcast at
www.virtualshareholdermeeting.com/TRNS2026
|
|
|
Record Date:
July 13, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Items of Business
|
|
|
Board
Recommendation
|
|
➢ Proposal 1: Election of director nominees
|
|
|
For each nominee
|
|
➢ Proposal 2: To approve, on an advisory basis, the compensation of our named executive officers
|
|
|
For
|
|
➢ Proposal 3: To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending March 27, 2027
|
|
|
For
|
|
To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
|
||
|
|
|
||
|
|
|
|
|
|
|
|||||||||
|
Prior to the Meeting:
|
|||||||||
|
By Internet*
www.proxyvote.com
|
|
|
By Smartphone or Tablet
Vote your shares by scanning the QR code provided on the Notice of Internet Availability or proxy card (if you request one)
|
|
|
By Telephone*
1-800-690-6903
|
|
|
By Mail
Complete, date, sign and return the proxy card mailed to you (if you request one) or voting instruction card (if sent by your nominee)
|
|
During the Meeting:
|
|||||||||
|
By Internet* www.virtualshareholdermeeting.com/TRNS2026
|
|||||||||
|
|
|||||||||
|
*
|
You will need to provide the control number that appears on your Notice of Internet Availability of Proxy Materials, proxy card or voting instruction form. Voting by telephone, internet, smartphone and tablet closes on September 8, 2026 at 11:59 p.m. Eastern Time.
|
|
|
|
|
|
|
|
|
By Order of the Board of Directors
|
|
|
|
|
|
|
|
|
|
Thomas L. Barbato
Senior Vice President of Finance, Chief Financial Officer,
Treasurer, and Secretary
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
|
|
|
i
|
|
PROXY STATEMENT SUMMARY
|
|
|
1
|
|
QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS
|
|
|
3
|
|
PROPOSAL ONE: ELECTION OF DIRECTORS
|
|
|
8
|
|
PROPOSAL TWO: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS
|
|
|
13
|
|
PROPOSAL THREE: RATIFICATION OF SELECTION OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
|
|
14
|
|
REPORT OF THE AUDIT COMMITTEE
|
|
|
16
|
|
CORPORATE GOVERNANCE
|
|
|
17
|
|
EXECUTIVE OFFICERS
|
|
|
24
|
|
COMPENSATION DISCUSSION AND ANALYSIS
|
|
|
25
|
|
COMPENSATION COMMITTEE REPORT
|
|
|
40
|
|
CEO PAY RATIO
|
|
|
41
|
|
PAY VERSUS PERFORMANCE
|
|
|
42
|
|
DIRECTOR COMPENSATION
|
|
|
46
|
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
|
|
|
48
|
|
SECURITY OWNERSHIP OF MANAGEMENT
|
|
|
49
|
|
DELINQUENT SECTION 16(A) REPORTS
|
|
|
49
|
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
|
|
|
50
|
|
SHAREHOLDER NOMINATIONS AND PROPOSALS FOR THE 2027 ANNUAL MEETING
|
|
|
51
|
|
OTHER MATTERS
|
|
|
52
|
|
APPENDIX A
|
|
|
A-1
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
When:
|
|
|
Where:
|
|
|
Record Date:
|
|
Wednesday, September 9, 2026
12:00 p.m. Eastern Time
|
|
|
Via webcast at
www.virtualshareholdermeeting.com/TRNS2026
|
|
|
July 13, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Proposal
|
|
|
Board Vote
Recommendation
|
|
|
Page
Reference
|
|||
|
1.
|
|
|
Election of six director nominees
|
|
|
FOR each nominee
|
|
|
8
|
|
2.
|
|
|
To approve, on an advisory basis, the compensation of our named executive officers
|
|
|
FOR
|
|
|
13
|
|
3.
|
|
|
To ratify the selection of Deloitte & Touche LLP ("Deloitte") as our independent registered public accounting firm for the fiscal year ending March 27, 2027
|
|
|
FOR
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
|
Age
|
|
|
Recent Professional Experience
|
|
|
Committees
|
|
Craig D. Cairns*
|
|
|
61
|
|
|
President of Howe & Rusling, Inc.
|
|
|
CC**
|
|
Dawn G. DePerrior*♦
|
|
|
68
|
|
|
Retired Managing Director in EY's Healthcare Technology Consulting Practice
|
|
|
CC, NESGC, TC
|
|
Oksana S. Dominach*
|
|
|
62
|
|
|
Senior Vice President, Beer Finance of Constellation Brands, Inc.
|
|
|
AC**, CC, EC
|
|
Christopher P. Gillette*♦
|
|
|
65
|
|
|
Retired Lean Leader Sales & Marketing of GE Aviation
|
|
|
CC, NESGC, TC
|
|
Gary J. Haseley*♦
|
|
|
64
|
|
|
Chairman of Board of the Company; Retired Senior Vice President and General Manager of Kaman Automation, Control & Energy
|
|
|
EC**
|
|
Jaime A. Irick
|
|
|
52
|
|
|
President and Chief Executive Officer of the Company
|
|
|
EC
|
|
Mbago M. Kaniki*♦
|
|
|
48
|
|
|
Chief Executive Officer of Adansonia Management LLC
|
|
|
NESGC**, AC, EC
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
|
Age
|
|
|
Recent Professional Experience
|
|
|
Committees
|
|
Cynthia M. Langston*♦
|
|
|
65
|
|
|
Senior Vice President and Chief Information Officer at Excellus BlueCross BlueShield
|
|
|
TC**, AC
|
|
Robert L. Mecca*♦
|
|
|
55
|
|
|
Senior Vice President of Finance at Gilead Sciences
|
|
|
AC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
♦
|
|
|
- Director Nominee
|
|
|
AC
|
|
|
- Audit Committee
|
|
|
EC
|
|
|
- Executive Committee
|
|
*
|
|
|
- Independent
|
|
|
CC
|
|
|
- Compensation Committee
|
|
|
TC
|
|
|
- Technology Committee
|
|
**
|
|
|
- Chair
|
|
|
NESGC
|
|
|
- Nominating, Environmental, Social and Governance Committee
|
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
TABLE OF CONTENTS
|
•
|
Our Annual Report for fiscal 2026; and
|
|
•
|
Notice of 2026 Annual Meeting and Proxy Statement.
|
|
•
|
View our proxy materials for the Annual Meeting on the internet and vote; and
|
|
•
|
Request a printed copy of the proxy materials.
|
|
•
|
Telephone: call toll-free at 1-800-579-1639;
|
|
•
|
Internet at www.proxyvote.com; or
|
|
•
|
Email at [email protected] with your control number (the number located in the shaded bar on the reverse side of the Notice of Internet Availability) in the subject line. In the message, include your full name and address, and state that you want to receive a paper copy of current and/or future proxy materials.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposal
|
|
|
Description
|
|
|
Vote Required
|
|
|
Board
Recommendation
|
|
|
Effect of
Abstentions
|
|
|
Effect of Broker
Non-Votes
|
|
One
|
|
|
Election of six director nominees
|
|
|
Plurality of the votes duly cast at the Annual Meeting(1)
|
|
|
For each nominee
|
|
|
None
|
|
|
None
|
|
Two
|
|
|
To approve, on an advisory basis, the compensation of our named executive officers
|
|
|
Majority of the votes duly cast at the Annual Meeting(2)
|
|
|
For
|
|
|
None
|
|
|
None
|
|
Three
|
|
|
To ratify the selection of Deloitte as our independent registered public accounting firm for the fiscal year ending March 27, 2027
|
|
|
Majority of the votes duly cast at the Annual Meeting(3)
|
|
|
For
|
|
|
None
|
|
|
Not applicable since this proposal is a routine matter on which brokers may vote
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Under our "plurality" voting standard, votes to "withhold" a vote will have no effect on the outcome of the vote, because nominees who receive the highest number of "for" votes will be elected.
|
|
(2)
|
The results of the advisory vote to approve the compensation of our named executive officers is not binding on the Board or the Compensation Committee. However, the Board and the Compensation Committee value the opinions expressed by our shareholders in their votes on this proposal and will consider the outcome of the vote when making future compensation decisions regarding our named executive officers.
|
|
(3)
|
We are presenting the selection of Deloitte as our independent registered public accounting firm to our shareholders for ratification. The Audit Committee will consider the outcome of this vote when selecting our independent registered public accounting firm for subsequent fiscal years.
|
TABLE OF CONTENTS
|
•
|
By internet at www.proxyvote.com.
|
|
•
|
By using your smartphone or tablet and scanning the QR code provided on the Notice of Internet Availability or proxy card if you received one.
|
|
•
|
By touch tone telephone: call toll-free at 1-800-690-6903.
|
|
•
|
By completing and mailing your proxy card (if you requested and received a printed copy of the proxy materials).
|
|
•
|
At the Annual Meeting: instructions on how to vote during the Annual Meeting webcast are posted at www.virtualshareholdermeeting.com/TRNS2026. Votes submitted during the Annual Meeting must be received no later than the closing of the polls at the Annual Meeting.
|
TABLE OF CONTENTS
|
•
|
You may submit a later-dated vote by internet or telephone (only your latest internet or telephone vote will be counted);
|
|
•
|
You may submit another timely, properly completed, later-dated proxy card;
|
|
•
|
You may send a timely written notice that you are revoking your proxy to our Corporate Secretary, 35 Vantage Point Drive, Rochester, New York 14624, which must be received no later than September 8, 2026; or
|
|
•
|
You may attend the Annual Meeting webcast and vote during the meeting. Attending the meeting without voting during the meeting will not, by itself, revoke a previously submitted proxy unless you specifically request your prior proxy be revoked.
|
TABLE OF CONTENTS
|
•
|
accessing our website, Transcat.com, and going to "SEC Filings" under "Investors";
|
|
•
|
writing to us at: Transcat, Inc., 35 Vantage Point Drive, Rochester, New York 14624, Attention: Corporate Secretary; or
|
|
•
|
telephoning us at (585) 352-7777.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cairns
|
|
|
DePerrior
|
|
|
Dominach
|
|
|
Gillette
|
|
|
Haseley
|
|
|
Irick
|
|
|
Kaniki
|
|
|
Langston
|
|
|
Mecca
|
|
|
TOTAL
|
|
|
Accounting and Internal Controls
|
|
|
|
|
✓
|
|
|
✓
|
|
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
|
|
✓
|
|
|
6
|
|||
|
Corporate Finance and Economics
|
|
|
✓
|
|
|
|
|
✓
|
|
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
|
|
✓
|
|
|
6
|
|||
|
Cybersecurity
|
|
|
|
|
✓
|
|
|
✓
|
|
|
|
|
|
|
✓
|
|
|
|
|
✓
|
|
|
|
|
4
|
|||||
|
ESG
|
|
|
|
|
✓
|
|
|
|
|
|
|
|
|
✓
|
|
|
✓
|
|
|
|
|
|
|
3
|
||||||
|
Human Resources/Compensation
|
|
|
✓
|
|
|
|
|
✓
|
|
|
|
|
✓
|
|
|
✓
|
|
|
|
|
|
|
|
|
4
|
|||||
|
Industry Experience
|
|
|
|
|
|
|
|
|
✓
|
|
|
✓
|
|
|
|
|
|
|
|
|
✓
|
|
|
3
|
||||||
|
International Operations Management
|
|
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
|
|
✓
|
|
|
|
|
|
|
✓
|
|
|
5
|
||||
|
Leadership Experience
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
9
|
|
Marketing
|
|
|
✓
|
|
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
|
|
|
|
|
|
5
|
||||
|
Mergers & Acquisitions
|
|
|
|
|
✓
|
|
|
✓
|
|
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
|
|
✓
|
|
|
6
|
|||
|
Operations
|
|
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
|
|
✓
|
|
|
✓
|
|
|
7
|
||
|
Other Public Company Experience
|
|
|
|
|
✓
|
|
|
✓
|
|
|
|
|
✓
|
|
|
✓
|
|
|
|
|
|
|
✓
|
|
|
5
|
||||
|
Risk Management
|
|
|
|
|
✓
|
|
|
✓
|
|
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
|
|
✓
|
|
|
6
|
|||
|
Strategic Planning
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
9
|
|
Technology
|
|
|
|
|
✓
|
|
|
✓
|
|
|
✓
|
|
|
|
|
✓
|
|
|
|
|
✓
|
|
|
|
|
5
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|||
|
Dawn G. DePerrior
|
|||
|
Age: 68
Director since: 2023
|
|
|
Board Committees:
Compensation
NESG
Technology
|
|
Ms. DePerrior retired as a managing director in Ernst & Young's (EY's) healthcare technology consulting practice in June 2022. A digital leader during her 40-year career, Ms. DePerrior has command of all aspects of Information Technology (IT) including strategy, business transformation, cyber security, digitization, data, analytics, innovation, mergers and acquisition integration, and finance. Her business technology career is uniquely defined by its breadth and depth of experience, including as a consultant and internal senior leader in manufacturing, distribution, consumer product goods, healthcare, and finance, enabling her to bring creative ideas, think "out of the box", and inspire large teams to solve strategic business problems. Prior to EY, Ms. DePerrior led business information technology transformation teams at Constellation Brands and the University of Rochester Medical Center. Ms. DePerrior was previously the board chair for the Villa of Hope, a Rochester based family services organization, and currently serves on the nominating committee. She is also a member of the board of directors for North Coast Holdings and the board of directors for Highland Hospital in Rochester, New York. Ms. DePerrior also served as a member of the board of directors of Evans Bancorp Inc. (formerly NYSE: EVBN) from May 2023 until its merger into NBT Bancorp Inc., in May 2025.
|
|||
|
Experience and Qualifications
|
|||
|
Ms. DePerrior's experience in leading business technology strategy and subsequent execution of complex business transformation programs powered by innovative technology uniquely positions her to support Transcat's strategic plan and growth. Her broad and deep leadership experience in business technology strategy, cyber, risk, data and analytics adds value as we continue the advancement of our technology strategy.
|
|||
|
|
|||
|
|
|||
|
Christopher P. Gillette
|
|||
|
Age: 65
Director since: 2023
|
|
|
Board Committees:
Compensation
NESG
Technology
|
|
Mr. Gillette retired as Lean Leader Sales & Marketing of GE Aerospace, a world-leading provider of jet and turboprop engines, components and integrated systems for commercial, military, business and general aviation aircraft, in October 2025 after serving in that role since January 2022. He served as VP Commercial Excellence at GE Digital, a software and Industrial Internet of Things service provider, from July 2020 to January 2022. From April 2015 to July 2020, Mr. Gillette held various senior positions at Philips, a focused leader in health technology.
|
|||
|
Experience and Qualifications
|
|||
|
Mr. Gillette brings to the Board extensive leadership and calibration industry experience, and considerable experience with client relations, sales and marketing. This experience, along with his strategic planning and market development experience, provide the Board with valuable knowledge as we continue to implement our growth strategy.
|
|||
|
|
|||
TABLE OF CONTENTS
|
|
|||
|
Gary J. Haseley
|
|||
|
Age: 64
Director since: 2015
|
|
|
Board Committee:
Executive (Chair)
|
|
Mr. Haseley has served as the Chairman of our Board since September 2020. He served as the Senior Vice President and General Manager of Kaman Automation, Control & Energy, a division of Kaman Corporation (NYSE: KAMN), a manufacturer in the aerospace industry and the third largest distributor in the power transmission/motion control market, until his retirement in November 2016. Prior to joining Kaman, from January 2001 to August 2012, Mr. Haseley served as President and Chief Executive Officer of Zeller Corporation, a distributor of electrical and automation components and solutions, which Kaman acquired in 2012. From 1995 until 2001, Mr. Haseley served as Zeller's Vice President of Sales. Prior to joining Zeller, Mr. Haseley held various engineering and sales positions. From May 2018 until December 2019, Mr. Haseley served on the board of directors of Jerash Holdings (US), Inc. (Nasdaq: JRSH). Mr. Haseley has also served on the board of directors of several other for-profit and not-for-profit entities.
|
|||
|
Experience and Qualifications
|
|||
|
Mr. Haseley brings extensive knowledge in the distribution and services markets to our Board. His role as Chief Executive Officer of Zeller Corporation and subsequent operational and sales roles at Kaman provide the Board with valuable insights into the leveraging of two market segments similar in synergies to our industry segments.
|
|||
|
|
|||
|
|
|||
|
Mbago M. Kaniki
|
|||
|
Age: 48
Director since: 2021
|
|
|
Board Committees:
NESG (Chair)
Audit
Executive
|
|
Mr. Kaniki has served as Chief Executive Officer of Adansonia Management LLC, an investment firm, since March 2013. He was Chief Executive Officer of Alva Charge LLC, an electric vehicle charging company, from May 2016 to April 2021. Mr. Kaniki worked for other investment firms from 2001 to 2013. He has served on the board of directors of for-profit and not-for-profit entities.
|
|||
|
Experience and Qualifications
|
|||
|
Mr. Kaniki has had valuable experience with numerous complex transactions, including debt and equity financings, and mergers and acquisitions. His extensive leadership experience and expertise in driving business growth and transformation through effective strategic planning and execution are valuable to the Board as the Company continues to implement its growth strategy.
|
|||
|
|
|||
|
|
|||
|
Cynthia M. Langston
|
|||
|
Age: 65
Director Since: 2022
|
|
|
Board Committees:
Audit
Technology (Chair)
|
|
Ms. Langston joined Excellus BlueCross BlueShield in 2014 and has served as its Senior Vice President and Chief Information Officer since July 2021, having previously served in advancing positions including most recently as Senior Vice President, Chief Analytics and Data Officer from July 2017 to July 2021 and Vice President, Enterprise Project Delivery Organization from 2014 to July 2017. Ms. Langston is also Chair of the board of directors of the YWCA of Rochester & Monroe County.
|
|||
|
Experience and Qualifications
|
|||
|
Ms. Langston brings to the Board extensive experience in enterprise strategy, information technology, cybersecurity and analytics across several major industries, as well as globally. Her qualifications for election to the Board include her extensive operational, technology and risk management expertise. Ms. Langston also brings deep management and leadership experience to the Board, having held several senior leadership positions during her career.
|
|||
|
|
|||
TABLE OF CONTENTS
|
|
|||
|
Robert L. Mecca
|
|||
|
Age: 55
Director Since: 2024
|
|
|
Board Committee:
Audit
|
|
Mr. Mecca is the Senior Vice President of Finance at Gilead Sciences, Inc. (Nasdaq: GILD), a leader in the life sciences industry. Mr. Mecca brings more than two decades of US and international life science industry experience in both biotech and large pharma. From July 2021 to July 2023, Mr. Mecca served as Senior Vice President of Finance at BeiGene USA (BeiGene), an oncology biotechnology company. Prior to his time at BeiGene, Mr. Mecca was Senior Vice President of Commercialization Finance at Bristol Myers Squibb, a global pharmaceutical company, where he held a series of expanding financial executive leadership positions with responsibilities for global manufacturing, international commercialization, R&D and business development. Mr. Mecca started his career as a technology & risk management consultant at Arthur Andersen LLP, an accounting firm. Mr. Mecca earned a master of business administration with a concentration in finance from The Wharton School of the University of Pennsylvania and a bachelor of administration in accounting from Loyola University in Maryland. Mr. Mecca served on the board of directors of the Emmanuel Cancer Foundation from June 2018 through December 2024.
|
|||
|
Experience and Qualifications
|
|||
|
Mr. Mecca brings to the board more than 25 years of financial experience in the life sciences industry with expertise in financial management, strategy development, business expansion and M&A. His extensive experience leading organizations through stages of growth and transformation are valuable to the board as we optimize our operations and continue our growth.
|
|||
|
|
|||
|
|
|||
|
Craig D. Cairns
|
|||
|
Age: 61
Director since: 2021
Term expires: 2027
|
|
|
Board Committee:
Compensation (Chair)
|
|
Mr. Cairns has served as the President since May 2003 and is the majority owner of Howe & Rusling, Inc., a wealth management services company. Mr. Cairns has more than 25 years of investment experience. Mr. Cairns currently serves as the Vice Chairman of the board of trustees of McQuaid Jesuit High School and is also the Chair of the Investment Committee for the Veterans' Outreach Center.
|
|||
|
Experience and Qualifications
|
|||
|
Mr. Cairns brings to the Board extensive leadership experience and considerable experience with client relations, capital allocation, sales and marketing. His experience with strategic planning and execution provides us with valuable knowledge as we continue to implement our growth strategy.
|
|||
|
|
|||
|
|
|||
|
Oksana S. Dominach
|
|||
|
Age: 62
Director since: 2019
Term expires: 2027
|
|
|
Board Committees:
Audit (Chair)
Compensation
Executive
|
|
Ms. Dominach is Senior Vice President, Beer Finance of Constellation Brands, Inc. (NYSE: STZ), a leading international producer and marketer of beer, wine and spirits. She was elected Vice President in 2004 and promoted to the Senior Vice President role in February 2016, and elected Assistant Treasurer in 2004 and promoted to Treasurer in June 2015. Previously, she served as Finance Director from 2003 to 2004. Ms. Dominach currently serves as treasurer and director of the not-for-profit Board of Constellation - Marvin Sands Performing Arts Center; a director of the Directors Advisory Council of the Rochester Division of Manufacturers and Traders Trust Company; a director of various Constellation subsidiaries; and a director of North Coast Holdings, Inc., and Lewis Tree Service, Inc.
|
|||
|
Experience and Qualifications
|
|||
|
Ms. Dominach brings to the Board more than 35 years of experience and expertise in financial strategy and risk management, as well as over ten years of experience participating on public and not-for-profit boards. Her capital structure management, risk management and corporate compliance expertise provide us with valuable insight and acumen as we continue to advance our growth strategy.
|
|||
|
|
|||
TABLE OF CONTENTS
|
|
|||
|
Jaime A. Irick
|
|||
|
Age: 52
Director since: 2026
Term expires: 2027
|
|
|
Board Committee:
Executive
|
|
Mr. Irick was appointed as our President and Chief Executive Officer in March 2026. Prior to joining the Company, he served as the Chief Executive Officer of The Pittsburgh Paints Company, a multi-billion dollar paints, stains and building products company serving homeowners and professionals, from December 2024 to February 2025. Mr. Irick served as Senior Vice President, Architectural Coatings, U.S. and Canada, and Traffic Solutions of PPG Industries, Inc., a global manufacturer and distributor of paints, coatings and specialty products, where he led a team of 7,000 employees to deliver innovative products and services for their customers, from May 2022 to December 2024 after having served as Vice President, Architectural Coatings, U.S. and Canada, from May 2019 to May 2022. Prior to his service at PPG, Mr. Irick was Vice President and President, Life Fitness, for Brunswick Corporation from January 2017 to December 2018. From 2003 to 2016, he held roles with increasing levels of responsibility in General Electric Company, including as a GE Company Officer. Before his business career, Mr. Irick served as a Field Artillery Officer in the U.S. Army for five years. Mr. Irick currently serves as a member of the board of directors of Illinois Tool Works Inc. (NYSE: ITW), a Fortune 300 industrial manufacturer.
|
|||
|
Experience and Qualifications
|
|||
|
Mr. Irick is an accomplished business-to-business executive known for leading large-scale industrial and technology enterprises, with a reputation for driving profitable growth through digital and business model optimizations, operational excellence and authentic leadership. This background as a business leader, along with his experience as a public company director, make him a compelling addition to our Board.
|
|||
|
|
|||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
Fiscal 2025
|
|
|
Fiscal 2026
|
|
|
Audit Fees
|
|
|
$563,725
|
|
|
$886,560
|
|
Audit-Related Fees
|
|
|
158,658
|
|
|
185,000
|
|
Tax Fees
|
|
|
-
|
|
|
-
|
|
All Other Fees
|
|
|
-
|
|
|
-
|
|
Total
|
|
|
$722,383
|
|
|
$1,071,560
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
•
|
reviewed and discussed the Company's audited consolidated financial statements for fiscal 2026 with management and Deloitte;
|
|
•
|
discussed with Deloitte the matters required to be discussed under auditing standards established from time to time by the Public Company Accounting Oversight Board and by SEC rules;
|
|
•
|
received and discussed the written disclosures and the letter from Deloitte required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent registered public accounting firm's communications with the Audit Committee concerning independence; and
|
|
•
|
discussed with Deloitte its independence.
|
|
|
|
|
|
|
|
|
Audit Committee:
|
|
|
|
|
||
|
|
|
Oksana S. Dominach, Chair
|
|
|
|
|
Mbago M. Kaniki
|
|
|
|
|
Cynthia M. Langston
|
|
|
|
|
Robert L. Mecca
|
|
|
|
|
|
|
|
(1)
|
The material in this report is not deemed to be "soliciting material," or to be "filed" with the SEC and is not to be incorporated by reference in any of our filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filings.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
|
Audit
|
|
|
Compensation
|
|
|
Executive
|
|
|
NESG
|
|
|
Technology
|
|
Cairns
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
DePerrior
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Dominach
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Gillette
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Haseley
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Irick
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Kaniki
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Langston
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Mecca
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Meetings held during fiscal 2026
|
|
|
4
|
|
|
9
|
|
|
4
|
|
|
6
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chair
|
|
|
|
|
|
Member
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
Lee D. Rudow, former President and CEO*;
|
|
•
|
Thomas L. Barbato, Chief Financial Officer and Treasurer;
|
|
•
|
Theresa A. Conroy, Chief Human Resources Officer;
|
|
•
|
Michael J. Haddad, Chief Information Officer; and
|
|
•
|
Michael W. West, Chief Operating Officer.
|
|
*
|
Mr. Rudow retired from his role as President and CEO effective March 28, 2026.
|
|
•
|
Total revenue was $331.9 million in fiscal 2026, an increase of $53.5 million or 19.2% from fiscal 2025.
|
|
•
|
Service segment revenue was $217.2 million, an increase of 19.7% from the prior fiscal year.
|
|
•
|
Distribution segment revenue was $114.7 million, an increase of 18.2% from the prior fiscal year.
|
|
•
|
Consolidated gross profit was $108.3 million in fiscal 2026, up 21.1% from fiscal 2025, and gross margin was 32.6% in fiscal 2026, a 50 basis point increase from fiscal 2025.
|
|
•
|
Net income was $5.4 million in fiscal 2026, a $9.1 million decrease from fiscal 2025, and diluted earnings per share were $0.57, down from $1.57 in fiscal 2025, due to acquisition-related expenses, increased incentive-based employee costs due to higher sales, executive transition costs, and continued investments in technology.
|
|
•
|
Adjusted EBITDA* was $48.7 million in fiscal 2026, an increase of $9.0 million or 22.7% from fiscal 2025.
|
|
*
|
Refer to Appendix A of this proxy statement for our definition of Adjusted EBITDA and a reconciliation of Adjusted EBITDA to the most directly comparable U.S. GAAP measure.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
AeroVironment, Inc.
|
|
|
Argan, Inc.
|
|
|
Axsome Therapeutics, Inc.
|
|
Cryoport, Inc.
|
|
|
Ducommun Incorporated
|
|
|
Graham Corporation
|
|
LeMaitre Vascular, Inc.
|
|
|
Ligand Pharmaceuticals Incorporated
|
|
|
Mesa Laboratories, Inc.
|
|
Omega Flex, Inc.
|
|
|
Powell Industries, Inc.
|
|
|
Standex International Corporation
|
|
Surmodics, Inc.
|
|
|
|
|
Willis Lease Finance Corporation
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Argan, Inc.
|
|
|
Axsome Therapeutics, Inc.
|
|
|
Cryoport, Inc.
|
|
Cytek Biosciences, Inc.
|
|
|
Ducommun Incorporated
|
|
|
Graham Corporation
|
|
LeMaitre Vascular, Inc.
|
|
|
Ligan Pharmaceuticals Incorporated
|
|
|
Mesa Laboratories, Inc.
|
|
Omega Flex, Inc.
|
|
|
Powell Industries, Inc.
|
|
|
Standex International Corporation
|
|
Tactile Systems Technology, Inc.
|
|
|
|
|
Willis Lease Finance Corporation
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Compensation Element
|
|
|
Key Characteristics
|
|
|
Link to Objectives
|
|
Base salary
|
|
|
Fixed; reviewed annually
|
|
|
To provide a competitive rate of pay
|
|
Annual performance-based cash incentive compensation
|
|
|
Variable; based on performance
|
|
|
To ensure that a portion of compensation is at risk and linked to performance
|
|
Long-term incentive awards
|
|
|
Variable; granted half in time-based awards and half in performance-based awards
|
|
|
To reinforce the NEO's long-term commitment to our success and, with respect to the performance-based awards, to align with shareholder interests
|
|
Benefits and perquisites
|
|
|
Fixed; substantially the same as the benefits offered to our other employees, including vacation, sick time, participation in a 401(k) plan and health and welfare plans
|
|
|
To provide competitive levels of benefits that promote health, wellness and financial security
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Name
|
|
|
Fiscal 2026 Base Salary Rate
|
|
|
Fiscal 2025 Base Salary Rate
|
|
Lee D. Rudow
|
|
|
$741,000
|
|
|
$649,600
|
|
Thomas L. Barbato
|
|
|
$396,240
|
|
|
$381,000
|
|
Theresa A. Conroy
|
|
|
$310,960
|
|
|
$299,000
|
|
Michael J. Haddad
|
|
|
$312,000
|
|
|
$300,000
|
|
Michael W. West
|
|
|
$364,000
|
|
|
$350,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
|
Fiscal 2026 Target
Percentage of Base Salary
|
|
Lee D. Rudow
|
|
|
100%
|
|
Thomas L. Barbato
|
|
|
50%
|
|
Theresa A. Conroy
|
|
|
40%
|
|
Michael J. Haddad
|
|
|
40%
|
|
Michael W. West
|
|
|
40%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Achievement
|
|
|
Percent of Annual Operating Plan
|
|
|
Corporate Payout Factor
|
|
Maximum
|
|
|
115%
|
|
|
200%
|
|
Target
|
|
|
100%
|
|
|
100%
|
|
Threshold
|
|
|
90%
|
|
|
33%
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Objective
|
|
|
Weight
|
|
|
Achievement
|
|
|
Payout
|
|
Adjusted EBITDA(1)
|
|
|
40%
|
|
|
94%
|
|
|
59%
|
|
Service segment gross profit
|
|
|
40%
|
|
|
90%
|
|
|
33%
|
|
Board's assessment of corporate performance
|
|
|
20%
|
|
|
|
|
150%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Refer to Appendix A of this proxy statement for our definition of Adjusted EBITDA and a reconciliation of Adjusted EBITDA to the most directly comparable U.S. GAAP measure.
|
|
|
|
|
|
|
Name
|
|
|
Performance-Based Cash Incentive Award
|
|
Lee D. Rudow
|
|
|
$494,115
|
|
Thomas L. Barbato
|
|
|
$132,544
|
|
Theresa A. Conroy
|
|
|
$83,214
|
|
Michael J. Haddad
|
|
|
$83,492
|
|
Michael W. West
|
|
|
$97,408
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Fiscal 2026
|
|
|
Equity Target
Percentage of Base
Salary
|
|
|
Long-Term Equity Award Opportunities
|
||||||
|
Name
|
|
|
PSUs(1)
|
|
|
RSUs(2)
|
|
|
Retention RSUs(3)
|
|||
|
Lee D. Rudow
|
|
|
338%
|
|
|
14,782
|
|
|
14,782
|
|
|
-
|
|
Thomas L. Barbato
|
|
|
125%
|
|
|
2,690
|
|
|
2,691
|
|
|
19,772
|
|
Theresa A. Conroy
|
|
|
65%
|
|
|
1,098
|
|
|
1,098
|
|
|
10,380
|
|
Michael J. Haddad
|
|
|
60%
|
|
|
1,016
|
|
|
1,017
|
|
|
5,190
|
|
Michael W. West
|
|
|
65%
|
|
|
1,285
|
|
|
1,285
|
|
|
12,028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The shares underlying the PSUs will vest after three years subject to our achieving specific cumulative Adjusted EBITDA objectives over the eligible three-year period ending in the fiscal year ending March 25, 2028, and subject to the terms of the award and continued employment through the vesting date.
|
|
(2)
|
The shares underlying the RSUs will vest on March 25, 2028, subject to the terms of the award and continued employment through the vesting date.
|
|
(3)
|
The shares underlying the Retention RSUs will vest on January 6, 2028, subject to the terms of the award and continued employment through the vesting date.
|
TABLE OF CONTENTS
|
•
|
Maximum cumulative Adjusted EBITDA - 150%
|
|
•
|
Target cumulative Adjusted EBITDA - 100%
|
|
•
|
Minimum cumulative Adjusted EBITDA - 50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum
|
|
|
Target
|
|
|
Maximum
|
|
|
Actual
|
|
|
Three-Year Cumulative Adjusted EBITDA
|
|
|
$100,862
|
|
|
$114,616
|
|
|
$128,370
|
|
|
$127,084
|
|
Payout
|
|
|
50%
|
|
|
100%
|
|
|
150%
|
|
|
146%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name and Principal Position
|
|
|
Fiscal
Year
|
|
|
Salary(1)
($)
|
|
|
Stock
awards(2)
($)
|
|
|
Non-equity
incentive plan
compensation(3)
($)
|
|
|
All other
compensation(4)
($)
|
|
|
Total
($)
|
|
Lee D. Rudow
Former President and
Chief Executive Officer
|
|
|
2026
|
|
|
737,000
|
|
|
4,613,932
|
|
|
494,115
|
|
|
17,153
|
|
|
5,862,200
|
|
|
2025
|
|
|
625,861
|
|
|
974,400
|
|
|
194,968
|
|
|
20,131
|
|
|
1,815,360
|
||
|
|
2024
|
|
|
639,282
|
|
|
1,127,440
|
|
|
652,700
|
|
|
21,038
|
|
|
2,440,460
|
||
|
Thomas L. Barbato
Chief Financial Officer
|
|
|
2026
|
|
|
396,000
|
|
|
1,695,231
|
|
|
132,544
|
|
|
11,625
|
|
|
2,235,400
|
|
|
2025
|
|
|
368,410
|
|
|
476,250
|
|
|
67,266
|
|
|
10,926
|
|
|
922,852
|
||
|
|
2024
|
|
|
338,913
|
|
|
437,018
|
|
|
207,691
|
|
|
11,207
|
|
|
994,829
|
||
|
Theresa A. Conroy
Chief Human Resources Officer
|
|
|
2026
|
|
|
311,000
|
|
|
832,082
|
|
|
83,214
|
|
|
10,294
|
|
|
1,236,590
|
|
|
2025
|
|
|
289,965
|
|
|
194,350
|
|
|
42,231
|
|
|
9,493
|
|
|
536,039
|
||
|
|
2024
|
|
|
243,284
|
|
|
228,556
|
|
|
115,933
|
|
|
9,194
|
|
|
596,967
|
||
|
Michael J. Haddad
Chief Information Officer
|
|
|
2026
|
|
|
312,000
|
|
|
502,099
|
|
|
83,492
|
|
|
9,922
|
|
|
907,513
|
|
|
2025
|
|
|
161,538
|
|
|
180,000
|
|
|
21,186
|
|
|
5,002
|
|
|
367,727
|
||
|
Michael W. West
Chief Operating Officer
|
|
|
2026
|
|
|
363,000
|
|
|
966,521
|
|
|
97,408
|
|
|
11,617
|
|
|
1,438,546
|
|
|
2025
|
|
|
344,817
|
|
|
441,760
|
|
|
49,434
|
|
|
12,858
|
|
|
848,869
|
||
|
|
2024
|
|
|
259,693
|
|
|
219,765
|
|
|
129,721
|
|
|
10,184
|
|
|
619,363
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The amounts shown in this column include cash compensation paid during the applicable fiscal year.
|
|
(2)
|
The long-term equity incentive awards granted to our NEOs in fiscal 2026 were granted approximately 50% in RSUs and approximately 50% in PSUs, based on the total fair market value of the awards. In addition, (a) Messrs. Barbato, Haddad and West and Ms. Conroy received Retention RSUs in fiscal 2026, and (b) Mr. Rudow received the Special Equity Award, granted 50% in RSUs and 50% in PSUs. The amounts in this column do not reflect the actual value realized by the recipient. The amounts shown in this column reflect the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 ("ASC 718") for RSUs granted during each fiscal year, except that no estimates for forfeitures have been included. A discussion of the assumptions used to calculate grant date fair value are set forth in Note 6 (Stock-Based Compensation) to the Consolidated Financial Statements in the Form 10-K. For fiscal 2026, the amounts also include the value of the PSUs based on the probable outcome of the performance conditions as of the date of grant. If the highest level of performance were achieved for the fiscal 2026 PSUs, the maximum potential value of the fiscal 2026 PSUs for Messrs. Rudow, Barbato, Haddad and West would be $1,874,949, $371,381, $140,269, and $177,407, respectively, and $151,590 for Ms. Conroy. If the highest level of performance were achieved for the Special Equity Award PSUs, the maximum potential value would be $1,585,500.
|
|
(3)
|
The amounts shown in this column reflect amounts earned during the applicable fiscal year under our annual performance-based cash incentive plan.
|
|
(4)
|
The amounts shown in this column reflect amounts paid by us in the applicable fiscal year to, or on behalf of, the NEO as Company matching contributions under our 401(k) Plan, executive life insurance premiums, and long-term care insurance premiums. The amounts in the All Other Compensation column for fiscal 2026 reflect the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
401(k) Plan Matches
($)
|
|
|
Insurance
($)
|
|
|
Long-term Care Insurance
($)
|
|
|
Lee D. Rudow
|
|
|
11,133
|
|
|
1,020
|
|
|
5,000
|
|
Thomas L. Barbato
|
|
|
10,605
|
|
|
1,020
|
|
|
-
|
|
Theresa A. Conroy
|
|
|
9,274
|
|
|
1,020
|
|
|
-
|
|
Michael J. Haddad
|
|
|
8,902
|
|
|
1,020
|
|
|
-
|
|
Michael W. West
|
|
|
10,597
|
|
|
1,020
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Name
|
|
|
Award
Type
|
|
|
Grant
Date
|
|
|
Estimated future payouts
under non-equity incentive
plan awards(1)
($)
|
|
|
Estimated future payouts under
equity incentive plan awards
(#)
|
|
|
All other
stock awards:
Number of
shares of
stock or units
(#)
|
|
|
Grant
date fair
value of
stock
awards(2)
($)
|
||||||||||||
|
|
|
|
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
|
|
|||||
|
Lee D.
Rudow
|
|
|
Annual
|
|
|
|
|
244,530
|
|
|
741,000
|
|
|
1,482,000
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
PSUs(3)
|
|
|
8/21/2025
|
|
|
|
|
|
|
|
|
7,391
|
|
|
14,782
|
|
|
22,173
|
|
|
|
|
1,249,966
|
||||||
|
|
RSUs(4)
|
|
|
8/21/2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,782
|
|
|
1,249,966
|
||||||||
|
|
Special
PSUs(5)
|
|
|
8/21/2025
|
|
|
|
|
|
|
|
|
6,250
|
|
|
12,500
|
|
|
18,750
|
|
|
|
|
1,057,000
|
||||||
|
|
Special
RSUs(6)
|
|
|
8/21/2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,500
|
|
|
1,057,000
|
||||||||
|
Thomas L.
Barbato
|
|
|
Annual
|
|
|
|
|
62,865
|
|
|
190,500
|
|
|
381,000
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
PSUs(3)
|
|
|
5/27/2025
|
|
|
|
|
|
|
|
|
1,345
|
|
|
2,690
|
|
|
4,035
|
|
|
|
|
247,588
|
||||||
|
|
RSUs(4)
|
|
|
5/27/2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,691
|
|
|
247,680
|
||||||||
|
|
Retention
RSUs(7)
|
|
|
1/6/2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,772
|
|
|
1,199,963
|
||||||||
|
Theresa A.
Conroy
|
|
|
Annual
|
|
|
|
|
39,468
|
|
|
119,600
|
|
|
239,200
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
PSUs(3)
|
|
|
5/27/2025
|
|
|
|
|
|
|
|
|
549
|
|
|
1,098
|
|
|
1,647
|
|
|
|
|
101,060
|
||||||
|
|
RSUs(4)
|
|
|
5/27/2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,098
|
|
|
101,060
|
||||||||
|
|
Retention
RSUs(7)
|
|
|
1/6/2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,380
|
|
|
629,962
|
||||||||
|
Michael J.
Haddad
|
|
|
Annual
|
|
|
|
|
39,600
|
|
|
120,000
|
|
|
240,000
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
PSUs(3)
|
|
|
5/27/2025
|
|
|
|
|
|
|
|
|
508
|
|
|
1,016
|
|
|
1,524
|
|
|
|
|
93,513
|
||||||
|
|
RSUs(4)
|
|
|
5/27/2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,017
|
|
|
93,605
|
||||||||
|
|
Retention
RSUs(7)
|
|
|
1/6/2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,190
|
|
|
314,981
|
||||||||
|
Michael W.
West
|
|
|
Annual
|
|
|
|
|
46,200
|
|
|
140,000
|
|
|
280,000
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
PSUs(3)
|
|
|
5/27/2025
|
|
|
|
|
|
|
|
|
643
|
|
|
1,285
|
|
|
1,928
|
|
|
|
|
118,271
|
||||||
|
|
RSUs(4)
|
|
|
5/27/2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,285
|
|
|
118,271
|
||||||||
|
|
Retention
RSUs(7)
|
|
|
1/6/2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,028
|
|
|
729,979
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Amounts represent the threshold, target and maximum payout levels for fiscal 2026 under our annual performance-based cash incentive compensation plan.
|
|
(2)
|
Amounts represent the aggregate grant date fair value of awards pursuant to ASC 718, Compensation - Stock Compensation. Additional details on accounting for stock-based compensation can be found in Note 6 to our consolidated financial statements contained in the Form 10-K.
|
|
(3)
|
The PSUs have a three-year performance period (ending on March 25, 2028, the last day of our 2028 fiscal year) subject to our achieving specific cumulative Adjusted EBITDA objectives over the eligible three-year period. The PSUs will vest subject to the performance achieved and continued employment through the vesting date, but may vest pro rata upon the NEO's earlier death, disability, retirement or termination without cause, including following a change in control of the Company, as described in "Potential Payments upon Termination or Change of Control" below.
|
|
(4)
|
Pursuant to the award agreements, these RSUs will vest on March 25, 2028, subject to the grantee's continued service through the vesting date, but may vest pro rata upon the NEO's earlier death, disability, retirement or termination without cause, including following a change in control of the Company, as described in "Potential Payments upon Termination or Change of Control" below.
|
|
(5)
|
Pursuant to the Special Equity Award agreement, the performance measure for these PSUs was achieving specified adjusted EBITDA objectives during fiscal 2026, subject to an additional one-year vesting period and continued employment through the vesting date of March 27, 2027. Shares underlying the Special Equity Award PSUs may vest earlier upon termination without cause, including following a change in control of the Company, as described in "Potential Payments upon Termination or Change of Control" below.
|
|
(6)
|
Pursuant to the Special Equity Award agreement, 4,167 shares vested on March 28, 2026 and 8,333 shares will vest on March 27, 2027, subject to the terms of the award and continued employment through the applicable vesting date. Shares underlying the Special Equity Award RSUs may vest earlier upon termination without cause, including following a change in control of the Company, as described in "Potential Payments upon Termination or Change of Control" below.
|
|
(7)
|
Pursuant to the award agreement, these Retention RSUs will vest on January 6, 2028, subject to the terms of the award and continued employment through the vesting date.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
Option Awards
|
|
|
Stock Awards
|
|||||||||||||||||||
|
Name
|
|
|
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
|
|
|
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
|
|
|
Option
Exercise
Price
($)
|
|
|
Option
Expiration
Date
|
|
|
Number of
Shares or
Units of
Stock That
Have Not
Vested
(#)
|
|
|
Market
Value of
Shares or
Units of
Stock
That Have
Not
Vested(1)
($)
|
|
|
Equity Incentive
Plan Awards:
Number of
Unearned
Shares, Units or
Other Rights
That Have Not
Vested
(#)
|
|
|
Equity
Incentive Plan
Awards:
Market or
Payout Value
of Unearned
Shares, Units
or Other
Rights That
Have Not
Vested(1)
($)
|
|
Lee D. Rudow
|
|
|
10,000
|
|
|
-
|
|
|
63.17
|
|
|
5/25/2027
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
3,925(2)
|
|
|
279,931
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
14,782(3)
|
|
|
1,054,252
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
8,333(4)
|
|
|
594,310
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,784(5)
|
|
|
269,875
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,925(6)
|
|
|
279,931
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,782(7)
|
|
|
1,054,252
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,500(8)
|
|
|
891,500
|
||||||||
|
Thomas L. Barbato
|
|
|
6,000
|
|
|
-
|
|
|
90.92
|
|
|
1/03/2027
|
|
|
|
|
|
|
|
|
||||
|
|
5,000
|
|
|
-
|
|
|
63.17
|
|
|
5/25/2027
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
1,919(2)
|
|
|
136,863
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
2,691(3)
|
|
|
191,922
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
19,772(9)
|
|
|
1,410,139
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,186(5)
|
|
|
84,586
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,918(6)
|
|
|
136,792
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,690(7)
|
|
|
191,922
|
||||||||
|
Theresa A. Conroy
|
|
|
2,000
|
|
|
-
|
|
|
63.17
|
|
|
5/25/2027
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
783(2)
|
|
|
55,844
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
1,098(3)
|
|
|
78,309
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
10,380(9)
|
|
|
740,302
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
524(5)
|
|
|
37,372
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
782(6)
|
|
|
55,772
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,098(7)
|
|
|
78,309
|
||||||||
|
Michael J. Haddad
|
|
|
|
|
|
|
|
|
|
|
730(2)
|
|
|
52,064
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
1,017(3)
|
|
|
72,532
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
5,190(9)
|
|
|
370,151
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
730(6)
|
|
|
52,064
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,016(7)
|
|
|
72,532
|
||||||||
|
Michael W. West
|
|
|
|
|
|
|
|
|
|
|
916(2)
|
|
|
65,329
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
2,000(10)
|
|
|
142,640
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
1,285(3)
|
|
|
91,718
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
12,028(9)
|
|
|
857,837
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
725(5)
|
|
|
51,707
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
916(6)
|
|
|
65,329
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,285(7)
|
|
|
91,718
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Calculated using the closing price of a share of our common stock on March 27, 2026 (the last trading day of fiscal 2026) of $71.32.
|
|
(2)
|
These RSUs, which convert into common stock on a one-for-one basis, will vest on March 27, 2027, subject to the grantee's continued service through each vesting date except as otherwise provided in the applicable award agreement.
|
|
(3)
|
These RSUs, which convert into common stock on a one-for-one basis, will vest on March 25, 2028, subject to the grantee's continued service through each vesting date except as otherwise provided in the applicable award agreement.
|
|
(4)
|
These RSUs, which convert into common stock on a one-for-one basis, will vest on March 27, 2027, subject to the grantee's continued service through the vesting date except as otherwise provided in the Special Equity Award agreement.
|
TABLE OF CONTENTS
|
(5)
|
These PSUs vested after three years subject to the grantee's continued service through the vesting date and our achieving specific cumulative Adjusted EBITDA objectives over the three-year period ended March 28, 2026.
|
|
(6)
|
These PSUs will vest after three years subject to the grantee's continued service through each vesting date except as otherwise provided in the applicable award agreement and our achieving specific cumulative Adjusted EBITDA objectives over the three-year period ending on March 27, 2027.
|
|
(7)
|
These PSUs will vest after three years subject to the grantee's continued service through each vesting date except as otherwise provided in the applicable award agreement and our achieving specific cumulative Adjusted EBITDA objectives over the three-year period ending on March 25, 2028.
|
|
(8)
|
These PSUs will vest based on our achieving specified adjusted EBITDA objectives during fiscal 2026, subject to an additional one-year vesting period and the grantee's continued employment through the vesting date of March 27, 2027 except as otherwise provided in the Special Equity Award agreement.
|
|
(9)
|
These Retention RSUs, which convert into common stock on a one-for-one basis, will vest on January 6, 2028, subject to the grantee's continued service through the vesting date except as otherwise provided in the applicable award agreement.
|
|
(10)
|
These RSUs, which convert into common stock on a one-for-one basis, will vest on April 11, 2027, subject to the grantee's continued service through each vesting date except as otherwise provided in the applicable award agreement.
|
|
|
|
|
|
|||
|
|
|
Stock awards
|
||||
|
Name
|
|
|
Number of shares acquired on vesting
(#)
|
|
|
Value realized on vesting(1)
($)
|
|
Lee D. Rudow
|
|
|
12,952
|
|
|
933,337
|
|
Thomas L. Barbato
|
|
|
3,686
|
|
|
267,686
|
|
Theresa A. Conroy
|
|
|
2,024
|
|
|
147,232
|
|
Michael J. Haddad
|
|
|
-
|
|
|
-
|
|
Michael W. West
|
|
|
1,725
|
|
|
124,947
|
|
|
|
|
|
|
|
|
|
(1)
|
The value realized on vesting is equal to the number of shares vested multiplied by the closing price of a share of our common stock on the vesting date (or if such date falls on a weekend or public holiday, the closing price of a share of our common stock on the date immediately prior to the vesting date on which our shares traded).
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Annual
Compensation
per the
Summary
Compensation
Table(1)
|
|
|
Voluntary
Resignation/
Termination
for Cause
|
|
|
Death or
Disability
|
|
|
Retirement
|
|
|
Termination
without Cause
|
|
|
Termination
in
Connection
with
Change in
Control
|
|
|
Lee D. Rudow
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Severance Payments(2)
|
|
|
|
|
$-
|
|
|
$-
|
|
|
$-
|
|
|
$1,500,000
|
|
|
$1,482,000
|
|
|
Annual Performance-Based Cash Incentive Award(3)
|
|
|
|
|
494,115
|
|
|
494,115
|
|
|
494,115
|
|
|
494,115
|
|
|
494,115
|
|
|
Option Awards(4)
|
|
|
|
|
81,500
|
|
|
81,500
|
|
|
81,500
|
|
|
81,500
|
|
|
81,500
|
|
|
PSUs(5)
|
|
|
|
|
-
|
|
|
181,132
|
|
|
181,132
|
|
|
1,817,586
|
|
|
2,225,683
|
|
|
RSUs(6)
|
|
|
|
|
-
|
|
|
553,388
|
|
|
553,388
|
|
|
937,230
|
|
|
1,928,493
|
|
|
Other Benefits (7)
|
|
|
|
|
-
|
|
|
-
|
|
|
198,000
|
|
|
-
|
|
|
40,000
|
|
|
Total
|
|
|
$5,862,200
|
|
|
$575,615
|
|
|
$1,310,135
|
|
|
$1,508,135
|
|
|
$4,830,431
|
|
|
$6,251,791
|
|
Thomas L. Barbato
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Severance Payments (2)
|
|
|
|
|
$-
|
|
|
$-
|
|
|
$-
|
|
|
$-
|
|
|
$396,240
|
|
|
Annual Performance-Based Cash Incentive Award(3)
|
|
|
|
|
132,544
|
|
|
132,544
|
|
|
132,544
|
|
|
132,544
|
|
|
132,544
|
|
|
Option Awards(4)
|
|
|
|
|
40,750
|
|
|
40,750
|
|
|
40,750
|
|
|
40,750
|
|
|
40,750
|
|
|
PSUs(5)
|
|
|
|
|
-
|
|
|
88,512
|
|
|
-
|
|
|
-
|
|
|
328,643
|
|
|
RSUs(6)
|
|
|
|
|
-
|
|
|
1,555,145
|
|
|
-
|
|
|
1,410,139
|
|
|
1,738,924
|
|
|
Other Benefits
|
|
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
12,000
|
|
|
Total
|
|
|
$2,235,400
|
|
|
$173,294
|
|
|
$1,816,951
|
|
|
$173,294
|
|
|
$1,583,433
|
|
|
$2,649,101
|
|
Theresa A. Conroy
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Severance Payments(2)
|
|
|
|
|
$-
|
|
|
$-
|
|
|
$-
|
|
|
$-
|
|
|
$155,480
|
|
|
Annual Performance-Based Cash Incentive Award(3)
|
|
|
|
|
83,214
|
|
|
83,214
|
|
|
83,214
|
|
|
83,214
|
|
|
83,214
|
|
|
Option Awards(4)
|
|
|
|
|
16,300
|
|
|
16,300
|
|
|
16,300
|
|
|
16,300
|
|
|
16,300
|
|
|
PSUs(5)
|
|
|
|
|
-
|
|
|
36,088
|
|
|
-
|
|
|
-
|
|
|
134,082
|
|
|
RSUs(6)
|
|
|
|
|
-
|
|
|
799,468
|
|
|
-
|
|
|
740,302
|
|
|
874,455
|
|
|
Other Benefits
|
|
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
6,000
|
|
|
Total
|
|
|
$1,236,590
|
|
|
$99,514
|
|
|
$935,070
|
|
|
$99,514
|
|
|
$839,816
|
|
|
$1,269,531
|
|
Michael J. Haddad
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Severance Payments(2)
|
|
|
|
|
$-
|
|
|
$-
|
|
|
$-
|
|
|
$-
|
|
|
$-
|
|
|
Annual Performance-Based Cash Incentive Award(3)
|
|
|
|
|
83,492
|
|
|
83,492
|
|
|
83,492
|
|
|
83,492
|
|
|
-
|
|
|
Option Awards(4)
|
|
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
PSUs(5)
|
|
|
|
|
-
|
|
|
31,238
|
|
|
-
|
|
|
-
|
|
|
124,525
|
|
|
RSUs(6)
|
|
|
|
|
-
|
|
|
422,722
|
|
|
-
|
|
|
370,151
|
|
|
494,747
|
|
|
Other Benefits
|
|
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Total
|
|
|
$907,513
|
|
|
$83,492
|
|
|
$537,452
|
|
|
$83,492
|
|
|
$453,643
|
|
|
$619,272
|
|
Michael W. West
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Severance Payments(2)
|
|
|
|
|
$-
|
|
|
$-
|
|
|
$-
|
|
|
$-
|
|
|
$364,000
|
|
|
Annual Performance-Based Cash Incentive Award(3)
|
|
|
|
|
97,408
|
|
|
97,408
|
|
|
97,408
|
|
|
97,408
|
|
|
97,408
|
|
|
Option Awards(4)
|
|
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
PSUs(5)
|
|
|
|
|
-
|
|
|
42,272
|
|
|
42,272
|
|
|
-
|
|
|
156,975
|
|
|
RSUs(6)
|
|
|
|
|
-
|
|
|
927,064
|
|
|
927,064
|
|
|
857,837
|
|
|
1,157,452
|
|
|
Other Benefits(7)
|
|
|
|
|
-
|
|
|
-
|
|
|
198,000
|
|
|
-
|
|
|
12,000
|
|
|
Total
|
|
|
$1,438,546
|
|
|
$97,408
|
|
|
$1,066,744
|
|
|
$1,264,744
|
|
|
$955,245
|
|
|
$1,787,835
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The amounts in this column are the total reported compensation for fiscal 2025 per the Summary Compensation Table presented earlier in this proxy statement. These amounts are provided for comparative purposes only.
|
TABLE OF CONTENTS
|
(2)
|
Represent post-employment base salary continuation payments.
|
|
(3)
|
Represents the annual performance-based cash incentive award earned as of the assumed termination date.
|
|
(4)
|
Represents the value of option awards vested as of the assumed termination date.
|
|
(5)
|
Represents the pro-rata value of vested PSUs as of the assumed termination date. For death, disability, or retirement, the value is determined as follows: (i) if the termination date is within the first 15 months of the performance period, shares underlying the PSUs are forfeited; (ii) if the termination date is within months 16 to 27 of the performance period, the pro-rata portion is determined by multiplying the number shares underlying a PSU award by a fraction, the numerator of which is the number of completed months during the vesting period and the denominator of which is 36; and (iii) if the termination date is after 27 months of the performance period, the recipient is eligible to receive the full PSU award.
|
|
(6)
|
For death, disability, or retirement, represents the pro-rata value of vested RSUs as of the assumed termination date calculated by multiplying the number shares underlying an RSU award by a fraction, the numerator of which is the number of completed months during the vesting period and the denominator of which is the number of months from the grant date to the vesting date.
|
|
(7)
|
Represents post-retirement health benefit plan benefits.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
Compensation Committee:
|
|
|
|
|
||
|
|
|
Craig D. Cairns (Chair)
|
|
|
|
|
Dawn G. DePerrior
|
|
|
|
|
Oksana S. Dominach
|
|
|
|
|
Christopher P. Gillette
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Fiscal
Year
|
|
|
Summary
Compensation
Table Total
for PEO(1)
|
|
|
Compensation
"Actually
Paid" to
PEO(2)
|
|
|
Average
Summary
Compensation
Table Total
for non-PEO
NEOs(3)
|
|
|
Average
Compensation
"Actually
Paid" to non-
PEO NEOs(4)
|
|
|
Value of Initial Fixed
$100 Investment
Based On:
|
|
|
Net
Income(7)
|
|
|
Company
Selected
Measure:
Adjusted
EBITDA(8)
|
|||
|
|
Company
TSR(5)
|
|
|
Peer
Group
TSR(6)
|
|
|||||||||||||||||||
|
2026
|
|
|
$5,862,200
|
|
|
$4,736,089
|
|
|
$1,454,512
|
|
|
$1,326,496
|
|
|
$149.65
|
|
|
$85.97
|
|
|
$5,376
|
|
|
$48,739
|
|
2025
|
|
|
$1,815,360
|
|
|
$103,862
|
|
|
$668,872
|
|
|
$225,781
|
|
|
$151.69
|
|
|
$87.72
|
|
|
$14,515
|
|
|
$39,733
|
|
2024
|
|
|
$2,440,460
|
|
|
$2,206,568
|
|
|
$838,329
|
|
|
$826,706
|
|
|
$227.04
|
|
|
$109.58
|
|
|
$13,647
|
|
|
$38,613
|
|
2023
|
|
|
$1,444,134
|
|
|
$1,422,311
|
|
|
$603,803
|
|
|
$600,973
|
|
|
$182.13
|
|
|
$105.15
|
|
|
$10,688
|
|
|
$30,421
|
|
2022
|
|
|
$1,353,485
|
|
|
$1,512,100
|
|
|
$597,959
|
|
|
$498,629
|
|
|
$165.32
|
|
|
$117.53
|
|
|
$11,380
|
|
|
$26,307
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Reflects compensation for Lee D. Rudow, our former CEO, for the applicable fiscal year as reported in the Summary Compensation Table for the applicable year.
|
|
(2)
|
The dollar amounts reported in this column represent the amount of "compensation actually paid," or CAP, to the PEO in the applicable fiscal year, as computed in accordance with the SEC's pay versus performance disclosure rules. The dollar amounts do not necessarily reflect the actual amount of compensation earned by or paid to the PEO during the applicable fiscal year. The following table provides additional information as to the amounts deducted from and added to the Summary Compensation Table Total for the PEO pursuant to the SEC's rules to determine CAP to the PEO:
|
|
|
|
|
|
|
|
|
Fiscal 2026
|
|
|
Summary Compensation Table Total for PEO
|
|
|
$5,862,200
|
|
Adjustments for stock awards and option awards
|
|
|
|
|
(Deduct): Aggregate value for stock awards and option awards included in Summary Compensation Table Total for the covered fiscal year
|
|
|
$(4,613,932)
|
|
Add: Fair value at year end of awards granted during the covered fiscal year that were outstanding and unvested at the covered fiscal year end
|
|
|
3,891,504
|
|
Add (Deduct): Year-over-year change in fair value at covered fiscal year end of awards granted in any prior fiscal year that were outstanding and unvested at the covered fiscal year end
|
|
|
(435,080)
|
|
Add: Vesting date fair value of awards granted and vested during the covered fiscal year
|
|
|
297,190
|
|
Add (Deduct): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during the covered fiscal year
|
|
|
(265,793)
|
|
(Deduct): Fair value at end of prior fiscal year of awards granted in any prior fiscal year that failed to meet the applicable vesting conditions during the covered fiscal year
|
|
|
-
|
|
Add: Change in incremental fair value of awards modified during the covered fiscal year
|
|
|
-
|
|
Add: Dividends or other earnings paid on awards in the covered fiscal year prior to vesting if not otherwise included in the Summary Compensation Table Total for the covered fiscal year
|
|
|
-
|
|
Compensation "Actually Paid" to PEO
|
|
|
$4,736,089
|
|
|
|
|
|
|
(3)
|
Reflects the average compensation for the non-PEO NEOs in each applicable fiscal year based on compensation amounts reported in the Summary Compensation Table for the applicable fiscal year. The following table shows the executives who are included as non-PEO NEOs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|
2025
|
|
|
2026
|
|
Thomas L. Barbato
|
|
|
|
|
X
|
|
|
X
|
|
|
X
|
|
|
X
|
|
|
Theresa A. Conroy
|
|
|
|
|
X
|
|
|
X
|
|
|
X
|
|
|
X
|
|
|
Michael J. Haddad
|
|
|
|
|
|
|
|
|
X
|
|
|
X
|
|||
|
Michael W. West
|
|
|
|
|
|
|
|
|
X
|
|
|
X
|
|||
|
Mark A. Doheny
|
|
|
X
|
|
|
X
|
|
|
X
|
|
|
|
|
||
|
James M. Jenkins
|
|
|
X
|
|
|
X
|
|
|
X
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
(4)
|
The dollar amounts reported in this column represent the average amount of CAP to the non-PEO NEOs in the applicable fiscal year, as computed in accordance with the SEC's pay versus performance disclosure rules. The dollar amounts do not necessarily reflect the actual average amount of compensation earned by or paid to the non-PEO NEOs during the applicable fiscal year. The following table provides additional information as to the amounts deducted from and added to the Average Summary Compensation Table Total for non-PEO NEOs pursuant to the SEC's rules to determine Average CAP to non-PEO NEOs:
|
|
|
|
|
|
|
|
|
Fiscal 2026
|
|
|
Summary Compensation Table Total for non-PEO NEOs
|
|
|
$1,454,512
|
|
Adjustments for stock awards and option awards
|
|
|
|
|
(Deduct): Aggregate value for stock awards and option awards included in Summary Compensation Table Total for the covered fiscal year
|
|
|
$(998,983)
|
|
Add: Fair value at year end of awards granted during the covered fiscal year that were outstanding and unvested at the covered fiscal year end
|
|
|
1,088,661
|
|
Add (Deduct): Year-over-year change in fair value at covered fiscal year end of awards granted in any prior fiscal year that were outstanding and unvested at the covered fiscal year end
|
|
|
(166,747)
|
|
Add: Vesting date fair value of awards granted and vested during the covered fiscal year
|
|
|
-
|
|
Add (Deduct): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during the covered fiscal year
|
|
|
(50,947)
|
|
(Deduct): Fair value at end of prior fiscal year of awards granted in any prior fiscal year that failed to meet the applicable vesting conditions during the covered fiscal year
|
|
|
-
|
|
Add: Change in incremental fair value of awards modified during the covered fiscal year
|
|
|
-
|
|
Add: Dividends or other earnings paid on awards in the covered fiscal year prior to vesting if not otherwise included in the Summary Compensation Table Total for the covered fiscal year
|
|
|
-
|
|
Compensation "Actually Paid" to non-PEO NEOs
|
|
|
$1,326,496
|
|
|
|
|
|
|
(5)
|
Total Shareholder Return, or TSR, reflects the cumulative return of a $100 investment from the beginning of fiscal 2022 through the end of each of the fiscal years in the table, calculated in accordance with Item 201(e) of Regulation S-K.
|
|
(6)
|
The index used for this purpose is the S&P Composite 1500 Life Sciences Tools & Services Industry Index.
|
|
(7)
|
Reported in thousands. Reflects Net Income as reported in the Company's Consolidated Statements of Operations and Comprehensive Income included in the Company's annual report on Form 10-K for the applicable fiscal year.
|
|
(8)
|
Reported in thousands. Adjusted EBITDA is a non-GAAP measure. Refer to Appendix A of this proxy statement for our definition of Adjusted EBITDA and a reconciliation of Adjusted EBITDA to the most directly comparable U.S. GAAP measure.
|
|
•
|
Adjusted EBITDA
|
|
•
|
Service Segment Gross Profit
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
Service
|
|
|
Annual Retainer ($)
|
|
Director
|
|
|
55,000
|
|
Board Chairman
|
|
|
60,000
|
|
Audit Committee Chair
|
|
|
20,000
|
|
Other Standing Committee Chair
|
|
|
15,000
|
|
Executive Committee Member
|
|
|
10,000
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
|
Fees Earned or
Paid in Cash(1)
($)
|
|
|
Stock
Awards(2)
($)
|
|
|
Total
($)
|
|
Craig D. Cairns
|
|
|
70,000
|
|
|
120,009
|
|
|
190,009
|
|
Dawn G. DePerrior
|
|
|
60,625
|
|
|
120,009
|
|
|
180,634
|
|
Oksana S. Dominach
|
|
|
95,000
|
|
|
120,009
|
|
|
215,009
|
|
Christopher P. Gillette
|
|
|
60,625
|
|
|
120,009
|
|
|
180,634
|
|
Charles P. Hadeed(3)
|
|
|
24,375
|
|
|
-
|
|
|
24,375
|
|
Gary J. Haseley
|
|
|
135,000
|
|
|
120,009
|
|
|
255,009
|
|
Mbago M. Kaniki
|
|
|
105,000
|
|
|
120,009
|
|
|
225,009
|
|
Cynthia M. Langston
|
|
|
70,000
|
|
|
120,009
|
|
|
190,009
|
|
Robert L. Mecca
|
|
|
55,000
|
|
|
120,009
|
|
|
175,009
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The amounts shown include the cash retainers earned by the directors during fiscal 2026.
|
|
(2)
|
Includes the aggregate grant date fair value of the RSUs granted during fiscal 2026 as computed in accordance with ASC 718. For each director, the number of RSUs granted was determined by dividing $120,000, the grant date value of the award, by $75.62, the closing price of our common stock on the date of grant. The table below presents the aggregate number of outstanding stock options for each of our non-employee directors as of March 28, 2026:
|
|
|
|
|
|
|
Name
|
|
|
Number of Shares
Underlying
Unexercised Options
|
|
Craig D. Cairns
|
|
|
10,000
|
|
Dawn G. DePerrior
|
|
|
10,000
|
|
Oksana S. Dominach
|
|
|
10,000
|
|
Christopher P. Gillette
|
|
|
10,000
|
|
Gary J. Haseley
|
|
|
-
|
|
Mbago M. Kaniki
|
|
|
10,000
|
|
Cynthia M. Langston
|
|
|
10,000
|
|
Robert L. Mecca
|
|
|
10,000
|
|
|
|
|
|
|
(3)
|
Mr. Hadeed retired from the Board effective August 1, 2025.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Name and Address of Beneficial Owner
|
|
|
Number of Shares of
Common Stock
Beneficially Owned
|
|
|
Percent of Class
|
|
BlackRock, Inc.
50 Hudson Yards
New York, NY 10001
|
|
|
598,357(1)
|
|
|
6.4%
|
|
Conestoga Capital Advisors and
Conestoga Funds
550 E. Swedesford Rd., Suite 120
Wayne, PA 19087
|
|
|
1,013,365(2)
|
|
|
10.8%
|
|
Hood River Capital Management LLC
2373 PGA Blvd., Suite 200
Palm Beach Gardens, FL 33410
|
|
|
545,816(3)
|
|
|
5.8%
|
|
Neuberger Berman Group LLC, et al.
1290 Avenue of the Americas
New York, NY 10104
|
|
|
932,152(4)
|
|
|
10.0%
|
|
Ophir Asset Management Pty Ltd
Level 27, Governor Philip Tower
One Farrer Place, Sydney
NSW 2000 Australia
|
|
|
482,038(5)
|
|
|
5.2%
|
|
Royce & Associates, LP
One Madison Avenue
New York, NY 10010
|
|
|
614,253(6)
|
|
|
6.6%
|
|
Vanguard Capital Management
100 Vanguard Blvd.
Malvern, PA 19355
|
|
|
475,732(7)
|
|
|
5.1%
|
|
|
|
|
|
|
|
|
|
(1)
|
This information is based on an amendment to Schedule 13G filed with the SEC on January 26, 2024 by BlackRock, Inc. ("BlackRock") with respect to shares beneficially owned by it and certain of its subsidiaries. BlackRock reports sole voting power with respect to 587,756 shares and sole dispositive power with respect to 598,357 shares.
|
|
(2)
|
This information is based on an amendment to Schedule 13G filed with the SEC on January 9, 2026 by Conestoga Capital Advisors, an investment company, and Conestoga Funds. Conestoga Capital Advisors reports sole voting power with respect to 943,437 shares and sole dispositive power with respect to 1,013,365 shares and Conestoga Funds reports sole voting and dispositive power with respect to 626,699 shares.
|
|
(3)
|
This information is based on an amendment to Schedule 13G filed with the SEC on February 17, 2026 by Hood River Capital Management LLC which reports sole dispositive power over 545,816 shares.
|
|
(4)
|
This information is based on an amendment to Schedule 13G filed with the SEC on February 4, 2025 by Neuberger Berman Group LLC, Neuberger Berman Investment Advisers LLC, Neuberger Berman Equity Funds and Neuberger Berman Genesis Fund. Neuberger Berman Group LLC and Neuberger Berman Investment Advisers LLC report shared voting power with respect to 912,931 shares and shared dispositive power with respect to 932,152 shares. Neuberger Berman Equity Funds and Neuberger Berman Genesis Fund report shared voting and shared dispositive power with respect to 548,206 shares.
|
|
(5)
|
This information is based on a Schedule 13G filed with the SEC on April 2, 2026 by Ophir Asset Management Pty Ltd which reports sole voting and dispositive power over 482,038 shares.
|
|
(6)
|
This information is based on a Schedule 13G filed with the SEC on April 22, 2026 by Royce & Associates LP which reports sole voting and dispositive power over 614,253 shares.
|
|
(7)
|
This information is based on a Schedule 13G filed with the SEC on April 30, 2026 by Vanguard Capital Management which reports sole voting power over 68,571 shares and sole dispositive power over 475,732 shares.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Name of Beneficial Owner
|
|
|
Number of Shares of
Common Stock
Beneficially Owned(1)
|
|
|
Percent
of Class(1)
|
|
Directors and Director Nominees
|
|
|
|
|
||
|
Craig D. Cairns
|
|
|
18,930(2)
|
|
|
*
|
|
Dawn G. DePerrior
|
|
|
6,291(3)
|
|
|
*
|
|
Oksana S. Dominach
|
|
|
15,933(4)
|
|
|
*
|
|
Christopher P. Gillette
|
|
|
8,291(5)
|
|
|
*
|
|
Gary J. Haseley
|
|
|
41,889(6)
|
|
|
*
|
|
Jaime A. Irick(7)
|
|
|
-
|
|
|
-
|
|
Mbago M. Kaniki
|
|
|
14,180(8)
|
|
|
*
|
|
Cynthia M. Langston
|
|
|
11,424(9)
|
|
|
*
|
|
Robert L. Mecca
|
|
|
6,291(10)
|
|
|
*
|
|
Named Executive Officers
|
|
|
|
|
||
|
Lee D. Rudow(11)
|
|
|
111,881(12)
|
|
|
1.2%
|
|
Thomas L. Barbato
|
|
|
15,656(13)
|
|
|
*
|
|
Theresa A. Conroy
|
|
|
4,372(14)
|
|
|
*
|
|
Michael J. Haddad
|
|
|
-
|
|
|
-
|
|
Michael W. West
|
|
|
27,108
|
|
|
*
|
|
All directors, director nominees and executive officers as a group (14 persons)
|
|
|
170,365(15)
|
|
|
1.8%
|
|
|
|
|
|
|
|
|
|
*
|
Indicates less than 1%.
|
|
(1)
|
The amounts reported by such persons are as of July 13, 2026, with percentages based on 9,359,810 shares issued and outstanding except where the person has the right to receive shares within the next 60 days (as indicated in the other footnotes to this table), which would increase the number of shares owned by such person and the number of shares outstanding. Under the rules of the SEC, "beneficial ownership" is deemed to include shares for which an individual, directly or indirectly, has or shares voting or dispositive power, whether or not they are held for the individual's benefit, and includes shares that may be acquired within 60 days, including, but not limited to, the right to acquire shares by the exercise of options or the vesting of restricted stock units. Shares that may be acquired within 60 days by the exercise of options are referred to in the footnotes to this table as "presently exercisable options" or restricted stock units. Unless otherwise indicated in the other footnotes to this table, each shareholder named in the table has sole voting and sole investment power with respect to all of the shares shown as owned by the shareholder.
|
|
(2)
|
Includes 430 shares held by the Howe & Rusling 401(k) Plan FBO Mr. Cairns, 1,910 shares held by Howe & Rusling Roth 401(k) Plan FBO Mr. Cairns, presently exercisable options to purchase 10,000 shares, and 1,587 restricted stock units.
|
|
(3)
|
Includes presently exercisable options to purchase 4,000 shares and 1,587 restricted stock units.
|
|
(4)
|
Includes presently exercisable options to purchase 10,000 shares and 1,587 restricted stock units.
|
|
(5)
|
Includes presently exercisable options to purchase 6,000 shares and 1,587 restricted stock units.
|
|
(6)
|
Includes 1,200 shares held by Haseley family trusts and 1,587 restricted stock units.
|
|
(7)
|
Mr. Irick is also our President and CEO.
|
|
(8)
|
Includes presently exercisable options to purchase 10,000 shares and 1,587 restricted stock units.
|
|
(9)
|
Includes presently exercisable options to purchase 8,000 shares and 1,587 restricted stock units.
|
|
(10)
|
Includes presently exercisable options to purchase 4,000 shares and 1,587 restricted stock units.
|
|
(11)
|
Mr. Rudow is our former President and CEO.
|
|
(12)
|
Includes presently exercisable options to purchase 10,000 shares.
|
|
(13)
|
Includes presently exercisable options to purchase 11,000 shares.
|
|
(14)
|
Includes presently exercisable options to purchase 2,000 shares.
|
|
(15)
|
Includes presently exercisable option to purchase 65,000 shares and 12,696 restricted stock units.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
By Order of the Board of Directors
|
|
|
|
|
|
|
|
|
|
Thomas L. Barbato
|
|
|
|
|
Senior Vice President of Finance, Chief Financial Officer, Treasurer, and Secretary
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
||||||
|
|
|
Fiscal Year Ended
|
|||||||
|
|
|
March 28, 2026
|
|
|
March 29, 2025
|
|
|
March 30, 2024
|
|
|
Net Income
|
|
|
$5,376
|
|
|
$14,515
|
|
|
$13,647
|
|
+ Interest Expense (Income), net
|
|
|
4,579
|
|
|
(27)
|
|
|
1,027
|
|
+ Tax Provision
|
|
|
2,613
|
|
|
3,811
|
|
|
4,792
|
|
+ Executive Transition Costs
|
|
|
1,706
|
|
|
-
|
|
|
-
|
|
+ Depreciation & Amortization
|
|
|
26,172
|
|
|
18,567
|
|
|
13,477
|
|
+ Transaction Expense
|
|
|
744
|
|
|
1,278
|
|
|
1,158
|
|
+ Gain on Acquisition/Divestiture-related items
|
|
|
-
|
|
|
(1,660)
|
|
|
-
|
|
+ Noncash Stock Compensation
|
|
|
7,549
|
|
|
3,248
|
|
|
4,512
|
|
Adjusted EBITDA
|
|
|
$48,739
|
|
|
$39,732
|
|
|
$38,613
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS